The Investigational New Drug (IND) Workshop
-Define an investigational drug, including off-label use of FDA approved drugs.
-Provide guidance on determining when the IND regulations apply to research -studies
-Discuss the preparation and submission of IND applications to FDA
-Review maintenance and safety reporting requirements
-Encourage participant discussion of case scenarios
Contact: Susan Nagorski